Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31511239

Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2019 Dec 5
First author
Hijiya N

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Hijiya N
      type
      Author
    2. name
      Maschan A
      type
      Author
    3. name
      Rizzari C
      type
      Author
    4. name
      Shimada H
      type
      Author
    5. name
      Dufour C
      type
      Author
    6. name
      Goto H
      type
      Author
    7. name
      Kang HJ
      type
      Author
    8. name
      Guinipero T
      type
      Author
    9. name
      Karakas Z
      type
      Author
    10. name
      Bautista F
      type
      Author
    11. name
      Ducassou S
      type
      Author
    12. name
      Yoo KH
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Hijiya N
      type
      Author
    2. name
      Maschan A
      type
      Author
    3. name
      Rizzari C
      type
      Author
    4. name
      Shimada H
      type
      Author
    5. name
      Dufour C
      type
      Author
    6. name
      Goto H
      type
      Author
    7. name
      Kang HJ
      type
      Author
    8. name
      Guinipero T
      type
      Author
    9. name
      Karakas Z
      type
      Author
    10. name
      Bautista F
      type
      Author
    11. name
      Ducassou S
      type
      Author
    12. name
      Yoo KH
      type
      Author
    bibliography ids
    1. nci-bib-554830db1c586d60d93d0c22
    book metadata
    content sha256
    a50baba181e59f3a15c221b3ec777ba2acff7ddaa64425c8e44dc5fe436e621d
    document type
    citation
    dois
    1. 10.1182/blood.2019000069
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:31511239
    immutable id
    pubmed:31511239@a50baba181e59f3a15c221b3ec777ba2acff7ddaa64425c8e44dc5fe436e621d
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    23
    name
    Blood
    nlm unique id
    7603509
    pages
    2036-2045
    volume
    134
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      31511239
      provenance
      batch id
      23ffe1e2a9e160b6dca0
      provider
      NCBI PubMed ESummary
      record sha256
      f46773437070418d4783db2a9c81ef93efb17f7e99198bd6776810de53d3b098
      response sha256
      d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
      retrieved at
      2026-09-09T23:47:44.690737+00:00
      publication date
      display
      2019 Dec 5
      precision
      day
      year
      2019
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/31511239/
      title
      Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia.

      Preserved source evidence · Not medical advice